We got here throughout a bullish thesis on Huntsman Company on Unfair Benefit’s Substack by AK. On this article, we are going to summarize the bulls’ thesis on HUN. Huntsman Company’s share was buying and selling at $11.72 as of January twenty sixth. HUN’s ahead P/E was 153.85 in keeping with Yahoo Finance.
Syda Productions/Shutterstock.com
Huntsman Company is a diversified chemical producer specializing in natural compounds, primarily polyurethanes and amines, serving a variety of finish markets and lowering reliance on any single sector. Its margin profile has traditionally been extra steady and better than friends, pushed by the amines section, that are specialty chemical substances with roughly 20% EBITDA, in comparison with primary polyurethanes that generate round 10% EBITDA. Presently, Huntsman is navigating a cyclical downturn, with chemical costs remaining depressed, however volumes have been rising steadily during the last two to a few quarters, indicating underlying demand resilience.
The corporate has additionally been disciplined in returning capital to shareholders, lowering shares excellent from 243 million in 2015 to 172 million at present, reflecting constant inventory buybacks. Aggressive pressures stay a consideration, notably from lower-cost producers in China and India, which may problem pricing and market share. Nevertheless, developments towards manufacturing onshoring may probably improve home demand and help income development if these macro shifts materialize. Whereas Huntsman faces each cyclical and structural challenges, its diversified portfolio, resilient specialty chemical substances enterprise, and shareholder-friendly capital allocation present a strong basis.
The mixture of enhancing volumes, steady specialty margins, and potential tailwinds from onshoring makes Huntsman an organization value monitoring, as it might current engaging alternatives for traders in search of publicity to specialty and primary chemical substances with a risk-adjusted development profile. General, Huntsman represents a measured funding case, balancing near-term cyclical headwinds with longer-term structural alternatives and powerful monetary self-discipline.
Beforehand, we lined a bullish thesis on Eastman Chemical Firm (EMN) by Mandatory-Damage5658 in November 2024, highlighting EMN’s edge from export management adjustments and compliance-driven demand. EMN’s inventory has depreciated by 31.84% since then resulting from sector weak point and cyclical headwinds. AK shares an analogous bullish view on Huntsman Company (HUN) however focuses on its diversified portfolio, specialty margins, and shareholder-friendly capital allocation.
